#KARUNATHERAPEUTICS News
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
benzinga.com Cantor Fitzgerald has initiated coverage on AbbVie Inc ABBV, a global pharma company. The analyst notes that the company has positioned itself to absorb Humira biosimilar…
One stock is dragging down the S&P 500's earnings growth
finance.yahoo.com Companies in the S&P 500 (^GSPC) have reported what's broadly been considered a solid Q1 earnings season for the index, with one key exception: drugmaker Bristol Myers…
Is Bristol Myers' Dividend in Danger?
finance.yahoo.com Bristol Myers Squibb (NYSE: BMY) pays investors an attractive dividend, which yields an incredibly high rate of 5.5%. That's nearly four times the S&P 500 average of 1.4%.…